LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX)

Q4 2015 13F Holders as of 31 Dec 2015

Type / Class
Equity / COMMON STOCK
Shares outstanding
363,214,619
Total 13F shares
109,649,652
Share change
+3,739,598
Total reported value
$1,459,682,001
Put/Call ratio
161%
Price per share
$13.31
Number of holders
116
Value change
+$54,951,710
Number of buys
58
Number of sells
49

Institutional Holders of LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) as of Q4 2015

As of 31 Dec 2015, LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) was held by 116 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 109,649,652 shares. The largest 10 holders included Artal Group S.A., FMR LLC, UBS ASSET MANAGEMENT AMERICAS INC, Ulys, L.L.C., VANGUARD GROUP INC, NEA Management Company, LLC, BlackRock Fund Advisors, BRIDGER MANAGEMENT, LLC, STATE STREET CORP, and LOOMIS SAYLES & CO L P. This page lists 116 institutional shareholders reporting positions in this security for the Q4 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.